Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Layla Dahmani

2PUBLICATIONS

25CO-AUTHORS

Haematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Jan 16, 2026

Fine-tuning BACH2 dosage balances stemness and effector function to enhance antitumor T cell therapy.

Alberto G Conti, Alexander C Evans, Teresa von Linde

|Mar 05, 2025

Aspirin prevents metastasis by limiting platelet TXA<sub>2</sub> suppression of T cell immunity.

Jie Yang, Yumi Yamashita-Kanemaru, Benjamin I Morris

Pageof 1

Frequent Collaborators

2 joint publications

Jie Yang

2 joint publications

Yumi Yamashita-Kanemaru

2 joint publications

Rahul Roychoudhuri

2 joint publications

Alexander C Evans

2 joint publications

Alberto G Conti

2 joint publications

Charlotte J Imianowski

2 joint publications

Klaus Okkenhaug

2 joint publications

Suman Mitra

1 joint publications

Ian A Parish

1 joint publications

Simone Puccio

Frequent Collaborators

2 joint publications

Jie Yang

2 joint publications

Yumi Yamashita-Kanemaru

2 joint publications

Rahul Roychoudhuri

2 joint publications

Alexander C Evans

Top Related Videos

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on : Jan 14, 2011

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

See more related videos

Top Related Videos

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on : Jan 14, 2011

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells

Published on : Jan 18, 2017

See more related videos